Title: Early Life Morphine Exposure Alters Microglial Activation and Immune Response in
Adult Rats
Authors: Alyssa Bartlett, Lauren Hanus, & Hillary Doyle
Faculty Sponsor: Anne Murphy, Ph.D.
Introduction: In the United States, 13 percent of pregnant women use illicit substances during
pregnancy; 19 percent abuse opiates, amounting to approximately one opiate abuser out of every
50 pregnant women. Prenatal exposure to opiates increases the risk of neonatal abstinence
syndrome (NAS) due to the sudden discontinuation of prolonged opioid exposure. NAS is
characterized by increased irritability, excessive crying, tremors, and dysregulation of sleepwake states as these infants undergo the complications of opiate withdrawal. NAS infants are at
a higher risk of developing neuropsychiatric and behavioral disorders later in life.
Microglia are the critical neuroimmune cells of the CNS, and we have previously shown that rats
who received morphine on the day of birth, in the absence of pain, had significantly elevated
levels of microglial activation as adults in the midbrain periaquductal gray (PAG). Elevated
levels of activated microglia are associated with a central neuroimmune response, suggesting that
these animals may be more vulnerable to inflammatory disease states.
Methods: To test this hypothesis, animals were administered either morphine or saline on the
day of birth. In adulthood (postnatal day 60-90), animals were implanted with Thermicron
iButtons to monitor body temperature and 7 days later, injected with lipopolysaccharide (LPS) to
elicit an immune response. At the end of the experiment, animals were sacrificed and brain tissue
stained immunohistochemically to examine density and activation levels of microglia.
Results: Data have been collected and are currently being analyzed for treatment-dependent
changes in body temperature and microglia expression.
Conclusion: We predict that animals that received morphine on the day of birth will show an
augmented febrile response to LPS and elevated levels of microglia activation, suggesting that
early life morphine exposure results in long-term changes in central immune function.

